Over 400 delegates including 20 speakers representing leading pharmaceutical organisations, biotech companies internationally renowned research and academic institutions will be present.
Over 20 presentations and case studies on the latest discoveries in CNS along with patient stratification and biomarker development for neuroscience.
2 interactive streams:
- Drug Discovery Strategies in CNS
- Translation, Stratification and Precision Medicine In Neuroscience
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Registration Available from: EUR 390.0
Speakers: Nick Brandon, Chief Scientist-Neuroscience, AstraZeneca, Johan Luthman, Vice President Neuroscience Clinical Development, Eisai, Pradeep Nathan, Vice President CNS Clinical Development and Head of Experimental Medicine, Heptares, Emilio Merlo Pich, Executive Director Neurology and Quantitative Medicine Neuroscience Therapeutic Area, Takeda, Thomas P. Misko, Lead Scientist and Senior Scientific Director, Translational Neuroscience, AbbVie, Janet Nicholson, Director, CNS Diseases Research, Boehringer Ingelheim, Holger Monenschein, Director, Medicinal Chemistry, Neuroscience Drug Discovery Unit, Takeda, Mikhail Kalinichev, Director, In Vivo Neurology, Ipsen, Johannes Krupp, Director, Ipsen, Magnus Ivarsson, Vice President, Head of Discovery, Rodin Therapeutics, Charlie Bailey, Global Head, Neuroscience BD&L, Novartis